Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Discontinued Operations

v2.4.0.6
Note 10 - Discontinued Operations
3 Months Ended
Mar. 31, 2013
Notes  
Note 10 - Discontinued Operations

Note 10 - Discontinued Operations

 

Pursuant to accounting rules for discontinued operations, the Company has classified all gain, revenue and expense related to the operations, assets, and liabilities of its bio-pharmaceutical business as discontinued operations.  For the three-month periods ended March 31, 2013 and 2012, Income from Discontinued Operations consists of the foreign currency transaction gains related to current liabilities associated with the discontinued operations that are denominated in Euros.